Anti-ERBB2 (Trastuzumab)-Mc-MMAD ADC

• Description:

  This ADC product is comprised of an anti-ERBB2 monoclonal antibody conjugated via a Mc linker to a MMAD. The MMAD is targeted to breast cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAD binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.

• Format:

  Solution

• Shipping Conditions:

  Ice Packs

• Storage Conditions:

  -20°C

• CAS Number:

  9007-83-4